ARAY logo

ACCURAY INC

ARAYNASDAQ
๐Ÿ† #4679 by market capEarnings Nov 4US Equity
$0.13โ–ผ $0.00 (โˆ’1.58%)
๐ŸŒ… Pre-market$0.13โ–ผ 2.29%Regular close ยท extended-hours price shown
๐Ÿ””
Track ARAY
Get earnings, price moves & breaking news on Telegram
Track
24hโ–ผ 1.6%
7dโ–ผ 0.3%
14dโ–ผ 22.2%
30dโ–ผ 54.8%
ytdโ–ผ 84.0%
1yโ–ผ 90.9%
๐ŸฆMarket Cap
$16M
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
-12.3%
Declining
๐Ÿ“ŠGross Margin
27.7%
Moderate
๐Ÿ’ตFCF Margin
-3.5%
Thin
โš–๏ธP/S Ratio
0.0x
Cheap
Otter Score
โ€”
Insufficient data

Trading Snapshot

Day Range
$0.13 โ€“ $0.14
52-Week Range
$0.12 โ€“ $1.58
Volume (shares)
1,176,816
Avg Volume (shares)
โ€”
Shares Outstanding
119.4M
Next Earnings
2026-11-04

Fundamentals Snapshot

Annual Revenue
$402M
Last Q Revenue
$101M
P/E Ratio
-0.3
P/S Ratio
0.0x
EPS (TTM)
$-0.40
Dividend Yield
0.00%
Dilution (1yr)
+2.2%
ARAY logo

ACCURAY INC

ARAY
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$402Mโ–ผ โˆ’12.3% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
27.7%โ–ผ โˆ’13.5% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isnโ€™t profitable yet.
โˆ’$26Mโ–ผ โˆ’437.3% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
โˆ’$13Mโ–ฒ +126.8% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing ownerโ€™s slice.
122.6Mโ–ฒ +2.2% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
โˆ’$143Mโ–ฒ +$20M YoY
StockOtter ยท stockotter.space

About ACCURAY INC

Accuray Incorporated specializes in the design, development, production, and sale of advanced radiosurgery and radiation therapy equipment aimed at treating tumors. Their market footprint spans across North and South America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and the broader Asia Pacific region. Among their core offerings is the CyberKnife System, a sophisticated robotic platform for stereotactic radiosurgery and stereotactic body radiation therapy. This system is employed to target both primary and metastatic tumors located outside the brain, specifically addressing areas such as the spine, breast, kidney, liver, lung, pancreas, and prostate. They also provide the TomoTherapy System, which encompasses the Radixact System, designed to deliver highly precise radiation treatments (up to 50 patients daily) through integrated planning, delivery, and data management capabilities. Complementing these are the iDMS data management system and the Accuray precision treatment planning system, both offering comprehensive solutions for treatment planning and data handling. In addition to their technology, Accuray offers crucial post-sale services, including customer support, system installation, training, and various other professional services. The company primarily engages directly with its clientele, which includes hospitals and specialized treatment centers, through its dedicated sales force. In the United States, they also leverage sales agents and group purchasing organizations, while internationally, their reach extends through distributors and sales agents. Established in 1990, Accuray Incorporated maintains its corporate headquarters in Madison, Wisconsin.

๐Ÿฆฆ

Otter Score Breakdown

How it's scoredFive components, each rated 1โ€“5โ˜… and equally weighted (20%), averaged to a 0โ€“100 score:๐Ÿ’Ž Quality โ€” gross margin๐Ÿš€ Growth โ€” revenue YoYโš–๏ธ Valuation โ€” P/S ratioโšก Momentum โ€” 30-day price change๐Ÿ’ง Dilution โ€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿ’งDilutionโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Insufficient data
โ€”/100

Analyst Ratings

โ“˜
Consensus
Sell
6 analysts
Strong Buy0
Buy0
Hold3
Sell1
Strong Sell2
Ratings as of Oct 2026

Latest News & Updates

PRNewsWireยท7d ago

Accuray to Report First Quarter Fiscal 2027 Financial Results on November 4, 2026

MADISON, Wis., Oct. 21, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2027, ended September 30, 2026, during a conference call hosted by compa

Defense Worldยท22d ago

Accuray Stockholders Approve Financing, Share Increase and Reverse Split Authority

Accuray (NASDAQ: ARAY) stockholders approved three proposals at the company's 2026 Special Meeting of Stockholders, including measures related to a planned preferred-stock financing, an increase in authorized common shar

PRNewsWireยท22d ago

Accuray Announces Stockholder Approval of Key Financing-Related Proposals and Appointment of New Independent Director

MADISON, Wis., Oct. 6, 2026 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) today announced that stockholders approved all proposals presented at the company's Special Meeting of Stockholders held on October 6, 2026,

GuruFocusยทSep 27

Accuray and Samsung NeuroLogica Advance Volumetric Imaging Collaboration for the Accuray CyberKnifeยฎ Platform

Accuray and Samsung NeuroLogica Advance Volumetric Imaging Collaboration for the Accuray CyberKnifeร‚ PlatformPR NewswireMADISON, Wis., Sept. 27, 2026MADISON, W

GuruFocusยทSep 11

Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities

Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive CapabilitiesPR Newsw

Defense WorldยทSep 7

BlackRock Inc. Makes New Investment in Accuray Incorporated $ARAY

BlackRock Inc. bought a new position in Accuray Incorporated (NASDAQ: ARAY) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investo